You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Perivascular Epithelioid Cell Neoplasms

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Perivascular Epithelioid Cell Tumors

Recruiting
  • Perivascular Epithelioid Cell Tumor, Malignant
    • Strasbourg, France
      Service d'Oncologie - CHU de Strasbourg - France
    Nov 7, 2022

    Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) Trial in Beijing (Sirolimus for Injection (Albumin Bound))

    Recruiting
    • Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
    • Sirolimus for Injection (Albumin Bound)
    • Beijing, China
      Beijing Jishuitan Hospital
    Nov 23, 2022

    Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)

    Recruiting
    • Soft Tissue Sarcoma
    • +9 more
    • Patient with Soft Tissue Sarcoma
    • Besancon, France
    • +13 more
    Oct 11, 2022

    PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

    Approved for marketing
    • PEComa, Malignant
    • +3 more
    • (no location specified)
    Mar 2, 2022

    PEComa Trial in United States (ABI-009)

    Completed
    • PEComa
    • Palo Alto, California
    • +8 more
    Apr 29, 2022

    Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung

    Recruiting
    • Lung Cancer Adenocarcinoma
    • +2 more
      • Sohag, Egypt
        Faculty of Medicine, Sohag University
      Jan 27, 2022

      Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

      Temporarily not available
      • Epithelioid Sarcoma (Ex-US Only)
      • +19 more
      • (no location specified)
      Oct 17, 2022

      Melanoma (Skin), Nevus, Nevus, Spitz Trial in Moscow, Nizhny Novgorod (Mobile phone application "ProRodinki")

      Recruiting
      • Melanoma (Skin)
      • +9 more
      • Mobile phone application "ProRodinki"
      • Moscow, Russian Federation
      • +1 more
      May 29, 2022

      PEComas: Natural History and Prognostic Factors

      Unknown status
      • PEComas
        • Strasbourg, France
          Service D'Hematologie Et D'Oncologie
        Apr 29, 2019

        Melanoma, Melanoma (Skin), Moles Trial in Nizhny Novgorod, Moscow (Non-invasive adhesive system (patch))

        Recruiting
        • Melanoma
        • +11 more
        • Non-invasive adhesive system (patch)
        • Nizhny Novgorod, Russian Federation
        • +1 more
        Jun 12, 2022

        Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

        Completed
        Has Results
        • Adult Alveolar Soft Part Sarcoma
        • +18 more
        • Portland, Oregon
        • +1 more
        Sep 23, 2021

        Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

        Active, not recruiting
        • Advanced Soft Tissue Sarcoma
        • +26 more
        • Doxorubicin Hydrochloride
        • +3 more
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Jan 6, 2023

        All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

        Active, not recruiting
        • All Malignancies
        • +11 more
        • Encinitas, California
        • +9 more
        May 20, 2022

        Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

        Active, not recruiting
        • Malignant Rhabdoid Tumors (MRT)
        • +10 more
        • San Francisco, California
        • +31 more
        Jan 17, 2023

        Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

        Suspended
        • Solid Tumor
        • ARID1A Gene Mutation
        • Greenville, South Carolina
          Prisma Health Cancer Institute
        Jan 10, 2023

        Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)

        Completed
        • Objective Response
        • Overall Survival
        • VIA combination treatment
        • Beijing, China
          Peking University People's Hospital
        Dec 9, 2022

        CD70-positive Advanced Urologic Tumors Trial in Shanghai (Anti-CD70 CAR-T cells)

        Recruiting
        • CD70-positive Advanced Urologic Neoplasms
        • Anti-CD70 CAR-T cells
        • Shanghai, Shanghai, China
          Changhai Hospital
        Aug 11, 2023

        Mature B-cell Tumors Trial (Nemtabrutinib)

        Not yet recruiting
        • Mature B-cell Neoplasms
        • (no location specified)
        Jan 13, 2023

        T-Cell and NK-Cell Tumor Trial

        Not yet recruiting
        • T-Cell and NK-Cell Neoplasm
          • (no location specified)
          Sep 28, 2023

          Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

          Not yet recruiting
          • Pleural Mesothelioma
          • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
          • Rozzano, MI, Italy
          • +5 more
          Nov 30, 2023

          Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

          Recruiting
          • Myeloproliferative Neoplasm
          • Fedratinib Pill
          • Tampa, Florida
            Moffitt Cancer Center
          Nov 28, 2022

          Chronic Kidney Diseases, End Stage Renal Disease, Arteriovenous Fistula Trial (SelfWrap Bioabsorbable Perivascular Wrap,

          Not yet recruiting
          • Chronic Kidney Diseases
          • +9 more
          • SelfWrap Bioabsorbable Perivascular Wrap
          • Untreated AVF Control
          • (no location specified)
          Aug 14, 2023

          Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma Trial in Chicago, Boston, Omaha (Pembrolizumab)

          Suspended
          • Lymphoma
          • +3 more
          • Chicago, Illinois
          • +3 more
          Jan 30, 2023

          Non-Hodgkin Lymphoma Trial in Sohag (real time pcr)

          Not yet recruiting
          • Non-Hodgkin Lymphoma
          • real time pcr
          • Sohag, Egypt
            Sohag University
          Jun 27, 2023

          CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

          Not yet recruiting
          • Central Nervous System Neoplasms
          • +6 more
          • B7-H3-CAR T cells
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          Apr 18, 2023